This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Chemical Stock Earnings Due on Nov 7: APD, ESI, TROX & ICL
by Anindya Barman
Let's take a look at how these chemical companies are poised ahead of their earnings release.
Dow's (DOW) Earnings and Revenues Surpass Estimates in Q3
by Zacks Equity Research
Dow (DOW) benefits from actions to reduce costs in Q3. It has completed roughly $1.37 billion cost synergy program in the quarter.
Dow's (DOW) Earnings & Revenues Beat Estimates in Q3
by Zacks Equity Research
Dow's (DOW) adjusted earnings of 91 per share for Q3 surpassed the Zacks Consensus Estimate of 72 cents.
Chemical Stock Earnings Due on Oct 24: DOW, EMN, AXTA & GRA
by Anindya Barman
Let's take a look at how these chemical companies are poised ahead of their earnings release.
Dow (DOW) Warms Up to Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Our proven model does not conclusively predict that Dow (DOW) is likely to beat the Zacks Consensus Estimate this quarter.
Dow Enables Recyclability through OPULUX HGT Optical Finishes
by Zacks Equity Research
Dow (DOW) unveils new optical finishing for PE-based packaging.
Dow (DOW) Announces Launch of AGILITY CE Plastic Resin
by Zacks Equity Research
Dow (DOW) introduces its consistent and high-quality resin made up of 70% recycled plastic.
Dow Inc. (DOW) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Dow Inc. (DOW) closed at $42.63 in the latest trading session, marking a +0.61% move from the prior day.
Dow (DOW) and Fuenix Ecogy to Produce 100% Circular Plastic
by Zacks Equity Research
The deal highlights Dow's (DOW) strategy to shift toward a circular economy for plastics.
Dow (DOW) to Retrofit FCDh Technology Into Plaquemine Cracker
by Zacks Equity Research
The retrofitting will enable Dow (DOW) to address rising customer demand for its businesses across major end-markets.
Dow (DOW) to Divest Acetone Derivatives Business to Altivia
by Zacks Equity Research
The divestment testifies Dow's (DOW) disciplined approach to portfolio management.
Company News For Jul 26, 2019
by Zacks Equity Research
Companies in the news are: TSLA, DOW, PYPL and F.
Dow's (DOW) Q2 Earnings Surpass Estimates, Revenues Trail
by Zacks Equity Research
Lower prices and volumes hurt Dow's (DOW) Q2 revenues. The company lowers its planned capital spending for 2019.
Dow's (DOW) Earnings Beat Estimates, Sales Lag in Q2
by Zacks Equity Research
Dow's (DOW) Q2 adjusted earnings per share of 86 cents beat the Zacks Consensus Estimate of 85 cents.
Dow (DOW) Gears Up for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Our proven model does not show that Dow (DOW) is likely to beat the Zacks Consensus Estimate this quarter.
Harvey Cripples Packaging Industry, Dump These Stocks
by Zacks Equity Research
As Harvey wreaked havoc on Texas, it had a domino effect on the packaging industry as chemical production was disrupted that led to increase in prices of the raw materials used by the industry.
Monsanto's Tech Improvements to Boost Innovation Platform
by Zacks Equity Research
Monsanto (MON) offers advanced Climate FieldView platform and NemaStrike technology for 2018 crop season. It intends to supply more Roundup Ready 2 Xtend soybeans in the United States.
Dow Chemical, TeselaGen Team Up to Expand Biodesign Platform
by Zacks Equity Research
Dow Chemical's (DOW) fully owned subsidiary Dow AgroSciences and TeselaGen collaborates to produce a state-of-the-art biological design automation platform that can expedite discovery work.
Dow, Saudi Aramco to Restructure Ownership in Sadara JV
by Zacks Equity Research
The potential ownership restructuring would increase Dow Chemical's (DOW) equity stake in Sadara JV to 50%.
DuPont to Exhibit Food Solutions Addressing Health Issues
by Zacks Equity Research
DuPont (DD) has come up with local food solutions that will be introduced at Food Ingredients Asia 2017 in response to health and nutrition concerns in Southeast Asia.
DuPont (DD) to Upgrade Probiotics Facility in Wisconsin
by Zacks Equity Research
DuPont's (DD) Nutrition & Health segment announced an expansion of its probiotics pilot facility in Madison, WI worth $10 million which will strengthen DuPont's position as a leading player in the probiotics industry.
Trump Passes Order to Fix U.S. Infrastructure: ETFs in Focus
by Zacks Equity Research
President Trump rolls back environmental policies in order to expedite Infrastructure projects.
Monsanto (MON) Signs Deal with ToolGen for CRISPR Technology
by Zacks Equity Research
Monsanto Company (MON) enhances genome-editing tools portfolio by signing a deal with ToolGen, in order to secure intellectual property rights for the latter's CRISPR technology.
Dow Chemical, Saudi Aramco JV Sadara Commissions Last Plant
by Zacks Equity Research
Dow Chemical's (DOW) Sadara joint venture in Saudi Arabia has commissioned its last plant, the region's first isocyanates facility.
Dow Chemical's (DOW) New $100M Center to Focus on Innovation
by Zacks Equity Research
Dow Chemical's (DOW) new $100 million innovation center will drive innovation and create growth synergies at intersection of organic chemistry and silicone science.